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Since neurocognitive performance is a possible
endophenotype for Attention Deficit Hyperactiv-
ity Disorder (ADHD) we explored the relationship
between four genetic polymorphisms and neuro-
cognitive performance in adults with ADHD. We
genotyped a sample of 45 adults with ADHD at four
candidate polymorphisms for the disorder (DRD4
48 base pair (bp) repeat, DRD4 120 bp duplicated
repeat, SLC6A3 (DAT1) 40 bp variable number of
tandem repeats (VNTR), and COMT Val158Met).
We then sub-grouped the sample for each poly-
morphism by genotype or by the presence of the
(putative) ADHD risk allele and compared the
performance of the subgroups on a large battery of
neurocognitive tests. The COMT Val158Met poly-
morphism was related to differences in IQ and
reaction time, both of the DRD4 polymorphisms
(48 bp repeat and 120 bp duplication) showed an
association with verbal memory skills, and the
SLC6A3 40 bp VNTR polymorphism could be
linked to differences in inhibition. Interestingly,
the presence of the risk alleles in DRD4 and
SLC6A3 was related to better cognitive perfor-
mance. Our findings contribute to an improved
understanding of the functional implications of
risk genes for ADHD.  2007 Wiley-Liss, Inc.
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INTRODUCTION
Studying the relationship between neurocognitive perform-
ance and candidate genetic polymorphisms for a psychiatric
disorder may aid the search for possible endophenotypes, in
order to simplify the complicated search for the genetic
background of psychiatric diseases [Doyle et al., 2005a]. In
Attention Deficit Hyperactivity Disorder (ADHD) in children,
several studies have implicated relationships between candi-
date genetic polymorphisms for thedisorder [for recent reviews
see Faraone and Khan, 2006; Waldman and Gizer, 2006] and
neurocognitive performance. Examples of these relationships
are the one between the 7-repeat allele of the 48 base pair (bp)
variable number of tandem repeats (VNTR) in the dopamine
receptor gene DRD4 and impulsive response style [Swanson
et al., 2000; Manor et al., 2002; Langley et al., 2004], and the
one between the 40 bp VNTR polymorphism in the dopamine
transporter gene SLC6A3 (formerly known as DAT1) and
sustained attention [Loo et al., 2003]. Although in behavioral
studies ADHD patients generally show worse performance on
certain cognitive tests compared to healthy controls [for
reviews see Nigg, 2005; Doyle, 2006], remarkably in some of
these studies the ADHD risk allele of a candidate poly-
morphism is associated with better performance on these tests
[for a recent review see Swanson et al., 2007].
In adults with ADHD, very little research has focused on
genetics yet. Candidate genes for adult ADHD are the same as
those for the disorder in children [for a review see Faraone,
2004]. The only study known to us in which the relationship
between genes and neurocognitive performance was inves-
tigated in young adults with ADHD [Barkley et al., 2006]
reported that participants with a 9/10 repeat genotype in the
SLC6A3 40 bp VNTR made more errors of omission on a
continuous performance test than the ADHD adults who were
homozygous for the 10-repeat allele. Interestingly, as with
some of the studies in children, the ADHD 10/10 risk genotype
did not lead to the predicted worse performance on a function
(in this example: sustained attention) in this study, either.
In light of the persistence hypothesis, which states that
genes may play a larger role in the persistent form of the
disorder [Faraone, 2004], the relationship between candidate
genes and neurocognitive performance in adult ADHD
deserves far more research effort than it has been given so
far. We therefore explored the relationship between four
polymorphisms in candidate genes (DRD4 48 bp repeat,
DRD4 120 bp duplicated repeat, SLC6A3 40 bp VNTR, and
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the catechol-O-methyltransferase gene COMT Val158Met)
and neurocognitive performance in adults with ADHD. The
DRD4 48 bp 7-repeat allele is over-represented in ADHD
[Faraone et al., 2005]. This allele is associated with a blunted
response to dopamine [Asghari et al., 1995]. TheDRD4 120 bp
L allele is associated with reduced DRD4 production [D’Souza
et al., 2004] and is a risk allele for ADHD [McCracken et al.,
2000]. The SLC6A3 40 bp 10-repeat allele is correlated with a
higher production of the dopamine transporter [Fuke et al.,
2001] and is over-represented in ADHD [Curran et al., 2001].
The Valine allele of the COMT Val158Met causes a faster
degradation of synaptic dopamine [Lachmanet al., 1996] and is
associated with ADHD [Eisenberg et al., 1999].
Forty-five adults meeting criteria for DSM-IV ADHD, 25
men, and 20 women, participated in this study. The average
age was 39.1 years (SD 9.9), and the average IQ was 101.0 (SD
18.2).Extensive descriptions of theparticipants, the diagnostic
procedures, and the exclusion criteria can be found in earlier
papers [Kooij et al., 2004; Boonstra et al., 2005a]. In brief,
participants underwent a standardized assessment by one of
two experienced psychiatrists including a semi-structured
diagnostic interview, structured interviews, and question-
naires for ADHD, and co-morbid psychiatric disorders. To be
given a diagnosis of adult ADHD, subjects had to (1) currently
meet at least 5 of 9 DSM-IV criteria of inattention and/or at
least 5 of 9 DSM-IV criteria of hyperactivity/impulsivity [this
cutoff point is in line with previous research; Biederman et al.,
2000], (2) meet at least 6 of 9 DSM-IV criteria of inattention
and/or at least 6 of 9 DSM-IV criteria of hyperactivity/
impulsivity in childhood, (3) describe a chronic persisting
course of ADHD symptoms from childhood to adulthood, and
(4) endorse amoderate to severe level of impairment attributed
to ADHD symptoms. Participants were medication free at
the time of testing andnonehadan IQof below75 (as estimated
with four subtests from the WAIS-III: Block Design, Picture
Arrangement, Vocabulary, and Arithmetic). The study was
conducted in compliance with the Code of Ethics of the World
Medical Association and the local Medical Ethical Committee
approved the study. All subjects completed a written informed
consent form before inclusion in the study.
DNA was isolated from EDTA-anticoagulated blood [Miller
et al., 1988]. Genotyping procedures for the 48 bp repeat and
the 120 bp tandem duplication (insertion/deletion) polymor-
phisms inDRD4 and the 40 bpVNTR in theSLC6A3 genewere
recently described by Kooij et al. [2007].
Genotypes for the COMT Val158Met polymorphism were
determined by pyrosequencing [Fakhrai-Rad et al., 2002] on a
PSQTM96 System (Pyrosequencing AB, Uppsala, Sweden)
using a three primer system, with 0.2 mM forward primer (50-
GGAGCTGGGGGCCTACTGTG-30) [Malhotra et al., 2002],
0.02 mM reverse primer carrying a universal tail (50-AGCG-
CTGCTCCGGTTCATAGATTGGCCCTTTTTCCAGGTCTGA-
30, universal part underlined) and 0.18 mM biotinylated
universal reverse primer (50-AGCGCTGCTCCGGTTCATA-
GATT-30). The reaction also contained 120 ng of genomic
DNA, 3mMdNTP, and 2UAmpliTaqGoldDNApolymerase in
GeneAmp PCR Gold buffer with 1.5 mM MgCl2 (Applied
Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). The
sequence primer used for the pyrosequence reaction was
50-GATGGTGGATTTCGC-30. The cycling conditions started
with 5min at 928C, followed by 45 cycles of 1min 928C, 1min at
59.88C and 1 min at 728C, ending with an extra 5 min 728C.
The amplifications were performed in a PTC-200 Multicycler
(MJ-Research via Biozym, Landgraaf, The Netherlands).
Neurocognitive tests were originally selected for a compar-
ison between adults with ADHD and normal control partic-
ipants [Boonstra et al., 2007]. Test selection was based on
theoretical accounts for ADHD [e.g., Pennington and Ozonoff,
1996; Barkley, 1997]. We selected tests for five areas of
executive functioning, which is defined by Welsh and
Pennington [1988] as ‘‘. . .the ability tomaintainanappropriate
problem solving set for attainment of a future goal (p. 201)’’:
fluency (generate different solutions for a problem), planning
(plan the steps needed to solve a problem), working memory
(keep information online), set shifting (shift to another
problem solving solution), and inhibition (withhold ones
actions). An overview of the tests is provided in Table I. Next
to the tests for executive functioning (EF), we included several
neurocognitive tests for functions that are required to perform
EF tests, but that are not tapping EF functions per se. In this
manner, we aimed to control for performance on these abilities
in the performance on EF tasks (see Table I).
For each polymorphism, genotype distribution was shown to
be in Hardy–Weinberg equilibrium. Study participants were
then grouped according to genotype or presence of at least one
risk allele, based on results from earlier studies. Table II
provides an overview of the different polymorphisms and the
frequency of genotypes.
We compared the subgroups with respect to their neuro-
cognitive performance. If variables were not normally dis-
tributed (originally or after transformation), we used non-
parametric tests. Effect sizes of significant findings are
expressed as Cohen’s d. Because of small samples (and
hence little power to detect small effects) and the novelty of
the subject we decided to maintain an alpha level of 0.05
(two-sided). Degrees of freedomdiffered slightly for some tests,
due to missing data. Table III summarizes our findings. Only
results with a P-value below 0.05 are mentioned (other data
available from the first author).
For the DRD4 48 bp repeat polymorphism, the group with
7-repeat allele(s) performed better than the group without
7-repeat alleles on a verbal short termmemory task (WAIS-III
Digit Span-Forward). In contrast, for two other tasks measur-
ing visuo-constructive ability (WAIS-III Block Design) and set
shifting (Wisconsin Card Sorting Test), it was the group
without any 7-repeat alleles that performed better. For the
DRD4 120 bp duplicated repeat polymorphism, the L/L group
performed better on a measure for verbal memory (the Dutch
version of the California Verbal Learning Test) than the
L/SþS/S group. For the SLC6A3 40 bp VNTR polymorphism,
the group with two 10-repeat alleles showed faster inhibition
(on theChangeTask) than the other group (9/9þ 9/10þ 11/10).
For the COMT Val158Met polymorphism the Val/Met sub-
group had a significantly higher Full Scale IQ (as estimated
with the WAIS-III) than the Val/Val subgroup. Part of this
difference can be explained by the significant lower score of
the Val/Val group on the WAIS-III subtest Block Design. The
Val/Val group also showed slower reaction times (on the
Continuous Performance Test) than both other groups. In
general, accompanying effect sizes were medium to large
(Table III).
An intriguing general trend in our results for three of the
four investigated polymorphisms is reflected by the counter-
intuitive findings of a better performance in the groups
carrying the ADHD risk alleles or genotypes. The 7-repeat
allele on theDRD448bp repeat polymorphism, associatedwith
reduced receptor functioning, was related to better perform-
ance on a verbal short term memory task. The L allele on the
DRD4 120 bp insertion/deletion, associated with reduced
receptor availability, was associated with better performance
onverbalmemory. The 10/10-repeat genotype of theSLC6A3 is
associated with higher transporter expression, but was linked
to faster inhibition in our study. Adults with ADHD have been
shown to perform worse on tasks for verbal memory and
inhibition in earlier studies [for reviews see Lijffijt et al., 2005;
Schoechlin and Engel, 2005; Boonstra et al., 2005b], so one
would expect the risk alleles for the disorder to be associated
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with worse rather than better performance on cognitive
measures. As indicated above, a similar trend is manifest in
some of the literature on ADHD in children [Oh et al., 2003;
Kim et al., 2006; Swanson et al., 2007] and the study on young
adults with the disorder by Barkley et al. [2006]. This poses
important questions with respect to the relationship between
genetic risk, clinical symptoms, and neurocognitive perform-
ance in the disorder. Bellgrove et al. [2005] suggested that
indeed the risk polymorphisms for ADHD may be related to
clinical features of the disorder, but not necessarily to the
neurocognitive defects associated with it. Fossella et al. [2002]
have raised the interesting explanation that both higher
and lower than average levels of synaptic dopamine may
lead to neurocognitive impairment, which could clarify the
counterintuitive results (the allele leading to higher levels of
dopamine not necessarily being the one associated with better
TABLE I. Overview of EF, EF Tasks, Non-EF, and Non-EF Tasks
EF EF test Reference Non-EF Non-EF test Reference
Fluency—verbal WO Luteijn and van der
Ploeg [1983]
Vocabulary WAIS-V Wechsler et al. [2000]
COWAT Benton and Hamsher
[1989]
Vocabulary WAIS-V Wechsler et al. [2000]
Fluency—figural RFFT Ruff [1988] Perceptual-motor
skill
BVRT-C Sivan [1992]
Planning TOL Schnirman et al. Object manipulation PP(both hands) Tiffin [1968]
[1998] Visuo-constructive
abilities
WAIS-BD Wechsler et al. [2000]
Inhibition ChT-SSRT Logan and Burkell
[1986]
Response speed Included in dependent
variable
—
CPT Conners [1995] Response speed Included in EF test
(MRT)
—
SCWT Stroop [1935];
Hammes [1971]
Color naming Included in dependent
variable
—
CDT Bachorowski and
Newman [1985]
Motor speed FTT Halstead [1947]
Set shifting ChT-CR Logan and Burkell
[1986]
Alternating
movement
PP (assemblies) Tiffin [1968]
WCST Grant and Berg
[1948]
Categorization SORT Luteijn and van der
Ploeg [1983]
Working memory— WAIS-DS-B Wechsler et al. [2000] Verbal short term VLGT Mulder et al. [1996]
verbal memory WAIS-DS-F Wechsler et al. [2000]
WAIS-LNS Wechsler et al. [2000] Verbal short term VLGT Mulder et al. [1996]
memory WAIS-DS-F Wechsler et al. [2000]
Working memory—
visual
SOP Petrides and Milner
[1982]
Visual short term
memory
BVRT-M Sivan [1992]
VMS-B Visual short term
memory
BVRT-M Sivan [1992]
Note. BVRT,BentonVisualRetentionTest (C,Copy;M,Memory); CDT,CircleDrawingTask;ChT,ChangeTask: an extension of theStopSignalTest [Logan
et al., 1984] (CR,ChangeResponse; SSRT, StopSignalReactionTime);COWAT,ControlledOralWordAssociationTest; CPT,ContinuousPerformanceTest;
EF, executive function; FTT, Finger Tapping Test; MRT, mean reaction time; NC, normal control; PP, Purdue Pegboard; RFFT, Ruff Figural Fluency Test;
SCWT, Stroop Color Word Test; SOP, Self Ordered Pointing Test; SORT, ‘Sorteren’ (sorting task from the Groninger Intelligentie Test); TOL, Tower of
London-Revised; VLGT, ‘Verbale Leer & Geheugen Test’: Dutch version of the California Verbal Learning Test [Delis et al., 1987]; VMS-B, Visual Memory
Span-Backwards from the Wechsler Memory Scale; WAIS, Wechsler Adult Intelligence Scale (BD, Block Design; DS-B, Digit Span-Backward; DS-F, Digit
Span-Forward; LNS, Letter & Number Sequencing; V, Vocabulary); WCST, Wisconsin Card Sorting Test; WO, ‘Woordopnoemen’, category fluency.
TABLE II. Frequencies of Genotypes Per Polymorphism Investigated
DRD4 (48 bp repeat) DRD4 (120 bp ins/del) SLC6A3 VNTR COMT Val158Met
2/2, n¼ 1 L/L, n¼27 10/10, n¼ 19 Val/Val, n¼10
2/3, n¼ 1 L/S, n¼ 15 10/9, n¼24 Val/Met, n¼ 21
2/4, n¼ 7 S/S, n¼3 9/9, n¼1 Met/Met, n¼ 14
2/5, n¼ 1 11/10, n¼1
2/7, n¼ 4
3/3, n¼ 1
3/4, n¼ 1
4/4, n¼ 16
4/5, n¼ 1
4/7, n¼ 10
4/8, n¼ 1
6/7, n¼ 1
N¼ 45 N¼45 N¼45 N¼ 45
Note. 48 bp repeat, 48 base pair (numbers indicate the number of repeat units per allele); COMT, catechol-O-
methyltransferase;DRD4, DopamineReceptor D4; L, long allele;Met,Methionine; S, short allele;SLC6A3, Solute
Carrier family 6,member 3, dopamine transporter (the numbers indicate the number of repeat units); Val, Valine;
VNTR, variable number of tandem repeats.
Genes and Neurocognitive Performance 399
T
A
B
L
E
II
I.
S
u
m
m
a
ry
of
R
es
u
lt
s
P
ol
y
m
or
p
h
is
m
N
eu
ro
co
g
n
it
iv
e
m
ea
su
re
R
a
w
m
ea
n
(s
ta
n
d
a
rd
d
ev
ia
ti
on
)
R
es
u
lt
S
ta
ti
st
ic
s
E
ff
ec
t
si
ze
(C
oh
en
’s
d
)
D
R
D
4
(4
8
b
p
V
N
T
R
)
W
A
IS
D
ig
it
S
p
a
n
F
or
w
a
rd
(1
)
9
.2
(2
.0
)a
1
or
2
7
R
a
ll
el
es
>
N
o
7
R
a
ll
el
es
t(
4
3
)¼
2
.1
8
,
P
¼
0
.0
3
5
0
.6
6
(v
er
b
a
l
m
em
or
y
)
(2
)
8
.3
(1
.6
)
G
ro
u
p
s
co
m
p
a
re
d
:
(1
)
A
t
le
a
st
1
7
-r
ep
ea
t
a
ll
el
e
(n
¼
1
5
)
(2
)
N
o
7
-r
ep
ea
t
a
ll
el
es
(n
¼
3
0
)
W
A
IS
B
lo
ck
D
es
ig
n
(1
)
3
3
.0
7
(1
5
.7
1
)
N
o
7
R
a
ll
el
es
>
1
or
2
7
R
a
ll
el
es
t(
4
3
)¼
2
.2
1
,
P
¼
0
.0
3
2
0
.7
0
(v
is
u
oc
on
st
ru
ct
iv
e
a
b
il
it
y
)
(2
)
4
3
.5
7
(1
4
.6
8
)
W
C
S
T
P
er
se
v
er
a
ti
v
e
er
ro
rs
(1
)
1
4
.6
7
(7
.0
5
)b
N
o
7
R
a
ll
el
es
>
1
or
2
7
R
a
ll
el
es
z
¼
2
3
5
,
P
¼
0
.0
1
9
0
.7
2
(s
et
sh
if
ti
n
g
)
(2
)
1
0
.3
8
(5
.4
3
)
D
R
D
4
(1
2
0
b
p
in
s/
d
el
)
C
a
li
fo
rn
ia
V
er
b
a
l
L
ea
rn
in
g
(1
)
5
7
.2
6
(7
.1
9
)
L
/L
>
L
/S
þ
S
/S
t(
4
3
)¼
3
.5
7
,
P
¼
0
.0
0
1
0
.3
7
T
es
t
(v
er
b
a
l
m
em
or
y
)
(2
)
4
8
.3
9
(9
.4
7
)
G
ro
u
p
s
co
m
p
a
re
d
:
(1
)
L
/L
(n
¼
2
7
)
(2
)
L
/S
þ
S
/S
(n
¼1
8
)
S
L
C
6
A
3
(D
A
T
1
)
C
h
a
n
g
e
T
a
sk
S
S
R
T
(i
n
h
ib
it
io
n
)
(1
)
2
0
1
.2
4
(5
7
.0
1
)
1
0
/1
0
>
1
0
/9
þ
9
/9
þ
1
1
/1
0
t(
4
2
)¼
2
.5
2
,
P
¼
0
1
6
0
.7
7
(2
)
2
4
8
.5
1
(6
3
.7
6
)
G
ro
u
p
s
co
m
p
a
re
d
:
(1
)
1
0
/1
0
(n
¼
1
8
)
(2
)
9
/9
þ
9
/1
0
þ
1
1
/1
0
(n
¼
2
6
)
C
O
M
T
W
A
IS
es
ti
m
a
ti
on
of
T
ot
a
l
IQ
(1
)
8
4
.6
7
(7
.5
8
)
V
a
l/
M
et
>
V
a
l/
V
a
l
F
(2
,4
1
)¼
6
.0
6
,
P
¼
0
.0
0
5
(2
)
1
0
7
.1
0
(1
7
.4
5
)
P
os
t
h
oc
te
st
:
P
¼
0
.0
0
3
1
.3
9
(3
)
1
0
0
.5
0
(1
7
.9
2
)
G
ro
u
p
s
co
m
p
a
re
d
:
(1
)
V
a
l/
V
a
l
(n
¼
9
)
(2
)
V
a
l/
M
et
(n
¼
2
1
)
(3
)
M
et
/M
et
(n
¼
1
4
)
W
A
IS
B
lo
ck
D
es
ig
n
(1
)
2
7
.3
0
(1
1
.1
4
)
V
a
l/
M
et
(a
)
&
M
et
/M
et
(b
)>
V
a
l/
V
a
l
F
(2
,4
2
)¼
5
.0
5
,
P
¼
0
.0
1
1
(v
is
u
oc
on
st
ru
ct
iv
e
a
b
il
it
y
)
(2
)
4
3
.6
2
(1
5
.9
3
)
P
os
t
h
oc
te
st
c :
(3
)
4
3
.8
6
(1
3
.9
3
)
(a
)
P
¼
0
.0
1
6
(a
)
1
.1
2
(b
)
P
¼
0
.0
2
5
(b
)
1
.2
9
C
on
ti
n
u
ou
s
P
er
fo
rm
a
n
ce
T
es
t
(1
)
3
8
7
.6
1
(4
4
.1
1
)b
V
a
l/
M
et
(a
)
&
M
et
/M
et
(b
)>
V
a
l/
V
a
l
w2
¼
7
.9
1
,
P
¼
0
.0
1
9
H
it
R
ea
ct
io
n
T
im
e
(r
es
p
on
se
(2
)
3
3
8
.3
6
(4
3
.2
5
)
P
os
t
h
oc
te
st
c :
sp
ee
d
)
(3
)
3
3
8
.1
0
(6
2
.5
9
)
(a
)
P
¼
0
.0
1
1
(a
)
1
.1
2
(b
)
P
¼
0
.0
1
4
(b
)
0
.8
9
N
ot
e.
T
h
e
d
ir
ec
ti
on
of
th
e
>
si
g
n
in
th
e
co
lu
m
n
‘R
es
u
lt
’i
n
d
ic
a
te
s
w
h
ic
h
g
ro
u
p
p
er
fo
rm
ed
b
et
te
r,
re
g
a
rd
le
ss
of
w
h
et
h
er
th
e
d
ep
en
d
en
t
v
a
ri
a
b
le
of
a
te
st
co
n
si
st
ed
of
a
ti
m
e
m
ea
su
re
,e
rr
or
s,
or
a
‘t
ot
a
lg
oo
d
sc
or
e’
;7
R
,
7
-r
ep
ea
t;
W
A
IS
,
W
ec
h
sl
er
A
d
u
lt
In
te
ll
ig
en
ce
S
ca
le
;
S
S
R
T
,
S
to
p
S
ig
n
a
l
R
ea
ct
io
n
T
im
e;
W
C
S
T
,
W
is
co
n
si
n
C
a
rd
S
or
ti
n
g
T
es
t.
a
R
a
w
sc
or
es
w
er
e
tr
a
n
sf
or
m
ed
to
ob
ta
in
n
or
m
a
li
ty
.
b
N
on
-p
a
ra
m
et
ri
c
te
st
s
w
er
e
u
se
d
.
c a
a
n
d
b
in
d
ic
a
te
g
ro
u
p
co
m
p
a
ri
so
n
s
a
s
d
en
ot
ed
b
y
th
e
sa
m
e
le
tt
er
s
in
th
e
co
lu
m
n
‘R
es
u
lt
’.
400 Boonstra et al.
performance). Swanson et al. [2007] have speculated that a
subgroup with a certain risk allele may show a partial
syndrome with behavioral problems but no cognitive deficits,
while the subgroup without this allele may show the full
syndrome with both behavioral and cognitive deficits. Another
speculative possibility can be found in the work by Mill et al.
[2006], who suggested that itmay be the combination of certain
risk genotypes rather than one single risk genotype that leads
to presence of cognitive dysfunction as well as behavioral
dysfunction. Similar hypotheses have been proposed by
Durston et al. [2005]. We would like to add to this discussion
that it would be worthwhile to analyze the effects of genetic
factors on cognitive functioning in healthy individuals, since
gene-by-disorder interactions might be expected. Further-
more, haplotypes rather thangenotypes shouldbe investigated
in the studies on cognitive performance in ADHD. In this way
(even) stronger association findings might be expected. For
example, it has recently been shown that a haplotype including
VNTRs in introns 8 and the 30 UTR of the SLC6A3 gene
encoding the dopamine transporter show stronger association
with ADHD than the 30 UTR VNTR alone [Asherson et al.,
2007]. Clearly, these relationships are far from crystallized yet
and deserve further research, especially in light of the current
emphasis on cognitive endophenotypes in genetic research on
psychiatric disorders.
In light of themany statistical comparisonswemade and the
low power to detect smaller effects, these results should be
viewed with caution and should be replicated before firm
conclusions can be drawn, but they can serve as point of
departure for future research into cognitive (endo)phenotypes
for ADHD in adults. Since most of the studied polymorphisms
will probably have relatively small effects on behavior, the
detection of these effects foremost requires larger samples.
Furthermore, our research should be extended to include other
genes related to ADHD [Faraone and Khan, 2006], other
possible endophenotypes [Castellanos and Tannock, 2002;
Doyle et al., 2005b], subtypes of ADHD [Eisenberg et al.,
1999], gender [Fossella et al., 2002; Nigg et al., 2004], and
co-morbid disorders [Biederman, 2004].
To summarize, we have tentatively shown a relationship
between several key genetic polymorphisms and neurocogni-
tive performance in adult ADHD: the COMT Val158Met
polymorphism seems to be related to differences in IQ and
reaction time, bothof theDRD4polymorphisms (48and120bp)
showed a connection with verbal memory skills, and the
SLC6A3 40 bp VNTR polymorphism could be linked to
differences in inhibition. These results support the suggestion
that cognitive endophenotypes may be an important tool to
understand the genetics of psychiatric disorders like ADHD,
given their more direct link to the genetic etiology.
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